Insys Therapeutics, Inc. Operating Expenses
Insys Therapeutics, Inc. reported Operating Expenses of $125.17 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-13
- Insys Therapeutics, Inc. operating expenses for the quarter ending 2019-03-31 was $125.17M, a 198.45% increase year-over-year.
- Insys Therapeutics, Inc. operating expenses for the quarter ending 2018-12-31 was $62.70M, a 31.90% increase year-over-year.
- Insys Therapeutics, Inc. operating expenses for the quarter ending 2018-09-30 was $46.79M, a 76.48% decline year-over-year.
- Insys Therapeutics, Inc. operating expenses for the quarter ending 2018-06-30 was $47.58M, a 2.85% decline year-over-year.
- Insys Therapeutics, Inc. operating expenses for fiscal 2018 was $199.00M, a 41.31% decline from fiscal 2017.
- Insys Therapeutics, Inc. operating expenses for fiscal 2017 was $339.08M, a 61.81% increase from fiscal 2016.
- Insys Therapeutics, Inc. operating expenses for fiscal 2016 was $209.56M, a 0.69% decline from fiscal 2015.
- Insys Therapeutics, Inc. operating expenses for fiscal 2015 was $211.01M, a 55.70% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $125.17M 10-Q · filed 2019-05-13 | $187.87M derived: sum of 2 quarters · filed 2019-05-13 | $234.65M derived: sum of 3 quarters · filed 2019-05-13 | $282.23M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-12-31 | $62.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $109.48M derived: sum of 2 quarters · filed 2019-03-13 | $157.06M derived: sum of 3 quarters · filed 2019-03-13 | $199.00M 10-K · filed 2019-03-13 | ||||
| 2018-09-30 | $46.79M 10-Q · filed 2018-11-09 | $94.36M derived: sum of 2 quarters · filed 2018-11-09 | $136.30M 10-Q · filed 2018-11-09 | $183.84M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-06-30 | $47.58M 10-Q · filed 2018-08-09 | $89.52M 10-Q · filed 2018-08-09 | $137.05M derived: sum of 3 quarters · filed 2019-05-13 | $335.99M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-03-31 | $41.94M 10-Q · filed 2019-05-13 | $89.47M derived: sum of 2 quarters · filed 2019-05-13 | $288.42M derived: sum of 3 quarters · filed 2019-05-13 | $337.39M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $47.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $246.48M derived: sum of 2 quarters · filed 2019-03-13 | $295.45M derived: sum of 3 quarters · filed 2019-03-13 | $339.08M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $198.94M 10-Q · filed 2018-11-09 | $247.91M derived: sum of 2 quarters · filed 2018-11-09 | $291.55M 10-Q · filed 2018-11-09 | $340.23M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $48.97M 10-Q · filed 2018-08-09 | $92.61M 10-Q · filed 2018-08-09 | $141.29M derived: sum of 3 quarters · filed 2018-08-09 | $192.12M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $43.63M 10-Q · filed 2018-05-10 | $92.32M derived: sum of 2 quarters · filed 2018-05-10 | $143.15M derived: sum of 3 quarters · filed 2018-05-10 | $199.66M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $48.69M 10-K · filed 2017-04-03 | $99.52M derived: sum of 2 quarters · filed 2017-11-03 | $156.02M derived: sum of 3 quarters · filed 2017-11-03 | $209.56M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $50.83M 10-Q · filed 2017-11-03 | $107.33M derived: sum of 2 quarters · filed 2017-11-03 | $160.87M 10-Q · filed 2017-11-03 | $162.37M 10-Q · filed 2016-11-03 | $217.32M derived: sum of 4 quarters · filed 2017-11-03 | |||
| 2016-06-30 | $56.50M 10-Q · filed 2017-08-07 | $110.04M 10-Q · filed 2017-08-07 | $111.54M 10-Q · filed 2016-08-05 | $166.49M derived: sum of 3 quarters · filed 2017-08-07 | $210.92M derived: sum of 4 quarters · filed 2017-08-07 | |||
| 2016-03-31 | $53.53M 10-Q · filed 2017-05-09 | $55.03M 10-Q · filed 2016-05-05 | $109.98M derived: sum of 2 quarters · filed 2017-05-09 | $154.41M derived: sum of 3 quarters · filed 2017-05-09 | $211.78M derived: sum of 4 quarters · filed 2017-05-09 | |||
| 2015-12-31 | $56.45M 10-K · filed 2017-04-03 | $100.88M derived: sum of 2 quarters · filed 2017-04-07 | $158.25M derived: sum of 3 quarters · filed 2017-04-07 | $211.01M 10-K · filed 2018-03-12 | $209.51M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $44.43M 10-K · filed 2017-04-03 | $101.80M derived: sum of 2 quarters · filed 2017-04-07 | $154.57M 10-Q/A · filed 2017-04-07 | $199.07M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2015-06-30 | $57.37M 10-Q/A · filed 2017-04-07 | $110.13M 10-Q/A · filed 2017-04-07 | $154.64M derived: sum of 3 quarters · filed 2017-04-07 | $187.51M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2015-03-31 | $52.76M 10-Q/A · filed 2017-04-07 | $97.27M derived: sum of 2 quarters · filed 2017-04-07 | $130.14M derived: sum of 3 quarters · filed 2017-04-07 | $164.09M derived: sum of 4 quarters · filed 2017-04-07 | ||||
| 2014-12-31 | $44.51M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03 | $77.38M derived: sum of 2 quarters · filed 2017-04-03 | $111.33M derived: sum of 3 quarters · filed 2017-04-03 | $135.52M 10-K · filed 2017-04-03 | ||||
| 2014-09-30 | $32.87M 10-Q · filed 2015-11-05 | $66.82M derived: sum of 2 quarters · filed 2015-11-05 | $91.02M 10-Q · filed 2015-11-05 | $111.59M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $33.95M 10-Q · filed 2015-08-06 | $58.15M 10-Q · filed 2015-08-06 | $78.72M derived: sum of 3 quarters · filed 2016-02-29 | $92.70M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $24.19M 10-Q · filed 2015-05-11 | $44.77M derived: sum of 2 quarters · filed 2016-02-29 | $58.74M derived: sum of 3 quarters · filed 2016-02-29 | $69.78M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $20.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $34.55M derived: sum of 2 quarters · filed 2016-02-29 | $45.59M derived: sum of 3 quarters · filed 2016-02-29 | $54.06M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $13.98M 10-Q · filed 2014-11-12 | $25.02M derived: sum of 2 quarters · filed 2014-11-12 | $33.49M 10-Q · filed 2014-11-12 | $45.31M derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | $11.04M 10-Q · filed 2014-08-12 | $19.51M 10-Q · filed 2014-08-12 | $31.33M derived: sum of 3 quarters · filed 2014-08-12 | $37.62M derived: sum of 4 quarters · filed 2014-08-12 | ||||
| 2013-03-31 | $8.47M 10-Q · filed 2014-05-14 | $20.30M derived: sum of 2 quarters · filed 2014-05-14 | $26.58M derived: sum of 3 quarters · filed 2014-05-14 | $33.05M derived: sum of 4 quarters · filed 2014-05-14 | ||||
| 2012-12-31 | $11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $18.11M derived: sum of 2 quarters · filed 2014-03-05 | $24.57M derived: sum of 3 quarters · filed 2014-03-05 | $31.29M 10-K · filed 2014-03-05 | ||||
| 2012-09-30 | $6.29M 10-Q · filed 2013-11-12 | $12.75M derived: sum of 2 quarters · filed 2013-11-12 | $19.47M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | $6.47M 10-Q · filed 2013-08-13 | $13.18M 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | $6.71M 10-Q · filed 2013-06-05 |